ANGLE plc (LON:AGL – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 2.35 and traded as high as GBX 2.90. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares trading hands.
ANGLE Stock Performance
The business has a fifty day moving average of GBX 2.35 and a 200-day moving average of GBX 3.60. The company has a market cap of £7.58 million, a PE ratio of -0.49 and a beta of 0.22. The company has a current ratio of 5.19, a quick ratio of 6.18 and a debt-to-equity ratio of 17.22.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
See Also
- Five stocks we like better than ANGLE
- Buy This Stock at 9:30 AM on MONDAY!
- The $100 Trillion AI Story No One Is Telling You
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
